International Clinical Psychopharmacology

Papers
(The median citation count of International Clinical Psychopharmacology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial31
UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients22
Innovation in psychopharmacology19
A comparative study of depressive and anxiety symptoms, insomnia, and sleepiness in patients with obstructive sleep apnea, restless legs syndrome, or both (CO-ROSA): preliminary findings from a retros14
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia14
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?14
Aripiprazole: examining the clinical implications of D2 affinity13
The role of personality traits in following quarantine orders during the COVID-19 pandemic12
Vitamin E in the treatment of tardive dyskinesia: a meta-analysis12
Assessing the relationship between antipsychotic drug use and prolidase enzyme activity and oxidative stress in schizophrenia patients: a case-control study11
On the benefits of therapeutic drug monitoring for patients undergoing treatment with antipsychotic agents11
Unhealthy lifestyle impacts on biological systems involved in stress response: hypothalamic–pituitary–adrenal axis, inflammation and autonomous nervous system10
No gender differences in the pharmacological emergency treatment of schizophrenia: results of a 21-year observation10
Efficacy and safety of agomelatine versus SSRIs/SNRIs for post-stroke depression: a systematic review and meta-analysis of randomized controlled trials10
Relevance of pharmacogenetic analyses and therapeutic drug monitoring of antidepressants for an individualized treatment of peripartum psychopathology10
Suicidality and psychotic episodes after starting aripiprazole: two case reports10
Prevalence and predictors of laxatives use in clozapine-related constipation: an observational study10
Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence10
Prevalence of obsessive-compulsive symptoms and their psychosocial correlates among medical students during COVID-19 pandemic9
Acceptability of transdermal antipsychotic patches by patients who refuse oral medication and their effectiveness in preventing recurrence of delirium: a retrospective observational study9
Neuroscience-based nomenclature as a teaching tool, introduction and pilot study9
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series9
Investigating the psychological effects of home quarantine during the early peaks of the COVID-19 pandemic: a survey from Iran9
In search of clinical targets for suicide prevention in major depressive disorder8
Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-108
Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting system7
Neuropsychiatric symptoms in a patient under cystic fibrosis transmembrane conductance regulator modulators treatment: a case report7
An investigation into the association between suicide mortality rate and lithium levels in potable water: a review study7
Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness7
Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial7
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies6
Micronized/ultramicronized palmitoylethanolamide improves depression and fatigue in coronavirus disease 2019 (COVID-19) survivors6
Pharmacologic treatment of depression in Alzheimer’s disease6
Diabetes mellitus in patients with chronic bipolar disorder: prevalence, clinical correlates and relationship with homocysteine6
Case report and systematic review of cerebellar vermis alterations in psychosis6
Antidepressant psychopharmacology: is inflammation a future target?6
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects5
Frequency, risk factors, and impacts on quality of life of the restless legs syndrome and side effects among antidepressant users in a tertiary hospital: an observational cross-sectional study5
Benefit of long-acting paliperidone in Huntington’s disease: a case report5
Does slow release oral morphine have impact on craving and impulsivity in heroin dependent individuals?5
Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol5
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results5
Successful treatment of switching from benzodiazepine to orexin receptor antagonists improves cognitive function in psychiatric disorders: four case reports5
Does tramadol dependence impair cognitive functions?5
Adjunctive music improves the tolerability of intravenous ketamine for bipolar depression5
Suicidality in a psychiatric inpatient unit: a 2-year retrospective study in Umbria, central Italy5
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?5
The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study5
Early administration of aripiprazole long-acting injectable in acute inpatients with schizophrenia: a clinical report5
Is mirtazapine augmentation effective for patients with obsessive-compulsive disorder who failed to respond to sertraline monotherapy? A placebo-controlled, double-blind, clinical trial4
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure4
Occurrence of involuntary movements after prolonged misuse of zolpidem: a case report4
Treatment of high dose of intravenous midazolam abuse: a case report4
Remission of functional motor symptoms following esketamine administration in a patient with treatment-resistant depression: a single-case report4
Clinical specificity profile for novel rapid acting antidepressant drugs4
Allergic reaction induced by subcutaneous administration of ketamine: a case report4
Psychometric validation of the Persian version of the Mental Health Knowledge Schedule4
Valbenazine for tardive dyskinesia: a systematic review and network meta-analysis4
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial4
Persistent suicidal ideation in major depressive disorder patients: still in need of empathic understanding4
DRESS syndrome: quetiapine associated case report and literature review4
Clinical correlates and prognostic impact of binge-eating symptoms in major depressive disorder4
Post-traumatic stress disorder and childhood emotional abuse are markers of subthreshold bipolarity and worse treatment outcome in major depressive disorder4
Trends of complications in patients with Parkinson’s disease in seven major cities of China from 2016 to 20194
Parasomnia induced by lemborexant: a case report4
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge4
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features4
A retrospective naturalistic study on the psychopharmacological treatment of schizoaffective disorder4
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia4
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?3
Crocus sativus (saffron) adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled trial3
Open issues in bipolar and antipsychotic treatments3
Increased risk of death compared to other antipsychotics in elderly clozapine users in Poland3
Fine-tuning of psychopharmacological treatments3
Interplay of environmental and clinical factors in psychiatric disorders3
Stroke, COVID-19, and other somatic aspects of psychiatric disorders treatments3
Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts3
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case3
Lurasidone as add-on to fluoxetine in obsessive-compulsive disorder with comorbid restrictive anorexia: a case report3
Case series on aripiprazole and dopamine supersensitivity psychosis3
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder3
Is Pilates effective in improving depressive disorders? A comprehensive overview3
The effect of early or late initiation of long-acting antipsychotics on the caregiver burden in schizophrenia3
l-carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial3
Risk of conversion to bipolar disorder in patients with late-onset major depression3
Social withdrawal and neurocognitive correlates in schizophrenia3
Managing depression in the elderly: real-world clinical considerations and perspectives2
Evaluating the influence of nonproblematic alcohol intake on the outcome of major depression2
Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review2
Successful clozapine rechallenge after myopericarditis: a case report2
Vortioxetine improves cognition in mild cognitive impairment2
Ketamine for depression: a potential role in requests for Medical Aid in Dying?2
Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database2
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study2
Safety and efficacy of daridorexant in the treatment of insomnia: a systematic review and meta-analysis of randomized controlled trials2
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study2
Catatonic postpartum paternal depression as a first debut of a bipolar disorder: a case report2
Relation of medication adherence to cognitive functions in egyptian patients with bipolar I disorder2
Bipolar disorder and Susac syndrome: a case report2
Differed spontaneous dissociative symptoms following the use of esketamine intranasal spray in a patient suffering from treatment-resistant depression: a case report2
It is ethical to publish successful case reports about patient with treatment-resistant depression2
A comparative study of the efficacy of venlafaxine and naltrexone for relapse prevention in patients with opioid use disorder attributed to tramadol2
Antidepressants use in Italy: an ecological study of national and regional trends and associated factors2
Longitudinal changes in clozapine dose in patients with treatment-resistant schizophrenia: a 5-year retrospective cohort study2
Assessment of clinical outcomes in patients with inflammatory arthritis: analysis from the UK Medical Cannabis Registry2
Effects of acute pain medications on posttraumatic stress symptoms in early aftermath of trauma2
Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea2
Relationship between clinical efficacy and plasma concentration-dose ratio of risperidone in patients with schizophrenia2
Lurasidone in first-episode psychosis with predominant depressive symptoms: a case report2
Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial2
Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder2
Focus on antipsychotics and related therapeutic drug monitoring2
Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder2
Examining age of onset phenotype in the spectrum of mood disorders2
Advances in the treatment of depression2
Manic episode in a patient with pancreatic adenocarcinoma: a case report2
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report2
Sex-controlled differences in sertraline and citalopram efficacies in major depressive disorder: a randomized, double-blind trial2
Type 2 diabetes mellitus is associated with manic morbidity in elderly patients with mood disorders2
Associations of adolescent psychosocial factors to later benzodiazepine use: a population-based follow-up study of adolescent psychiatric inpatients in Northern Finland2
0.081581115722656